2025-07-20 - Analysis Report
Okay, here's a report analyzing Colgate-Palmolive (CL) based on the data you provided.

## Colgate-Palmolive (CL) Stock Analysis Report

**Ticker:** CL
**Company:** Colgate-Palmolive Co.
**Description:** Colgate-Palmolive is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and veterinary products.

### 1. Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 14.04%
*   **VOO Cumulative Return:** 96.72%
*   **Absolute Divergence (CL - VOO):** -82.7%
*   **Divergence Range:** Max: 7.9%, Min: -82.8%
*   **Relative Divergence:** 0.1

**Analysis:** Colgate-Palmolive (CL) has significantly underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence suggests that CL is currently near the lowest end of its historical performance range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha    | Beta    | Cap(B) |
| ---------- | ------- | ------ | -------- | ------- | ------ |
| 2015-2017  | 13.0%   | 4.5%   | -16.0%   | 0.0     | 61.1   |
| 2016-2018  | -11.0%  | 65.2%  | -29.0%   | 0.1     | 48.2   |
| 2017-2019  | 7.0%    | 65.2%  | -22.0%   | 0.1     | 55.8   |
| 2018-2020  | 18.0%   | 65.2%  | -2.0%    | 0.6     | 69.3   |
| 2019-2021  | 30.0%   | 58.6%  | -19.0%   | 0.7     | 69.2   |
| 2020-2022  | 7.0%    | 69.0%  | 5.0%     | 0.7     | 63.9   |
| 2021-2023  | 6.0%    | 69.0%  | -12.0%   | 0.8     | 64.6   |
| 2022-2024  | 13.0%   | 69.0%  | -12.0%   | 0.8     | 73.7   |
| 2023-2025  | 1.0%    | 70.6%  | -48.0%   | 0.3     | 70.4   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  The CAGR shows fluctuating growth rates over the analyzed periods, with the most recent period (2023-2025) showing a significant decrease.
*   **MDD (Maximum Drawdown):**  The MDD is quite high, particularly in recent periods, indicating substantial potential losses from peak to trough.
*   **Alpha:** The Alpha is predominantly negative, implying that CL has generally underperformed its benchmark (S&P 500) on a risk-adjusted basis. Recent years show some improvement, but the latest period is significantly negative.
*   **Beta:** The Beta values range from 0.0 to 0.8. Beta values closer to 1 indicate market-like volatility, while values below 1 suggest lower volatility.
*   **Market Cap (B):** Market capitalization has generally increased over time, peaking in the 2022-2024 period.

### 2. Recent Price Action

*   **Current Price:** 86.84
*   **Previous Close:** 86.72
*   **Price Change:** 0.14
*   **5-Day Moving Average:** 87.704
*   **20-Day Moving Average:** 89.643
*   **60-Day Moving Average:** 90.5905

**Analysis:** The stock price is currently below all three moving averages (5, 20, and 60-day), suggesting a short-term downtrend. The slight price increase from the previous close may indicate a minor rebound or stabilization, but the overall trend remains downward based on these indicators.

### 3. Market Risk and Expected Return

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 41.61
*   **PPO:** -0.49
*   **Hybrid Signal:** Cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **Delta_Previous_Relative_Divergence:** 0.1 (+) - Short-term increase
*   **Expected Return:** -3599.3%

**Analysis:**

*   The MRI indicates a "Low Risk" market environment for CL.
*   The RSI is below 50, suggesting that the stock is not overbought and potentially undervalued.
*   The PPO is negative, which is further confirms downtrend.
*   The "Hybrid Signal" recommends a significant reduction in holdings (selling 69.9%) and increasing the cash position to 70%, highlighting a cautious outlook.
*   The recent increase in relative divergence is a sign that there is short-term uptrend.
*   The expected return is extremely low, indicating very poor outlook for a long-term investment.
*   The small price change of 0.14 does not suggest any significant immediate market reaction or volatility.

### 4. Recent News & Significant Events

*   **July 16, 2025:** Major business developments, regulatory changes, or market events.
*   **July 20, 2025:** Analyst discussion on performance, industry trends, and global economic factors.
*   **July 18, 2025:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **July 17, 2025:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news indicates a volatile environment for CL, influenced by a mix of business developments, regulatory changes, and market events. Investors should closely monitor company announcements and analyst reports to stay informed.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
| ---------- | ---- | ----------- |
| 2025-04-25 | 0.85 | 4.91 B$     |
| 2024-10-25 | 0.9  | 5.03 B$     |
| 2024-07-26 | 0.89 | 5.06 B$     |
| 2024-04-26 | 0.83 | 5.07 B$     |
| 2025-04-25 | 0.83 | 5.07 B$     |

**Analysis:**

*   **EPS:** EPS (Earnings Per Share) has fluctuated slightly over the analyzed quarters.
*   **Revenue:** Revenue has generally been stable.
* The EPS for the latest quarter(2025-04-25) is repeated.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | \$4.91B   | 60.82%        |
| 2024-12-31 | \$4.95B   | 60.30%        |
| 2024-09-30 | \$5.03B   | 61.08%        |
| 2024-06-30 | \$5.06B   | 60.62%        |
| 2024-03-31 | \$5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
| ---------- | --------- | --------- |
| 2025-03-31 | \$0.36B   | 190.08%   |
| 2024-12-31 | \$0.21B   | 348.58%   |
| 2024-09-30 | \$0.43B   | 169.43%   |
| 2024-06-30 | \$0.12B   | 594.31%   |
| 2024-03-31 | \$0.23B   | 296.96%   |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable.
*   **Profit Margin:** The profit margins have been consistently high, indicating strong operational efficiency.
*   **Equity:** The equity has fluctuated.
*   **ROE:** The ROE is extremely high, suggesting efficient use of equity to generate profits. However, such high ROE values should be investigated for potential accounting anomalies or one-time gains.

### 7. Overall Assessment

Based on the provided data, Colgate-Palmolive (CL) exhibits the following key characteristics:

*   **Underperformance:**  CL has significantly underperformed the S&P 500 over the specified period.
*   **Downtrend:** The stock price is currently in a short-term downtrend, trading below key moving averages.
*   **Cautious Outlook:** The Hybrid Signal recommends reducing holdings, reflecting a cautious outlook.
*   **High Profitability:** Profit margins are consistently high, but the extremely low expected return is concern.
*   **Volatile Environment:** Recent news suggests that CL is subject to various market and regulatory influences.

**Recommendation:**
The overall picture suggests caution. While the company maintains profitability, the underperformance relative to the S&P 500, the current downtrend, and the recommendation to reduce holdings point to potential risks. Furthermore, the extremely low expected return and negative Alpha values warrant careful consideration before investing. Monitoring upcoming news and company announcements is crucial.
